Telangiectatic osteosarcoma usually shows a better response to chemotherapy than conventional osteosarcoma. Survival rates with current chemotherapy protocols are within the range of 65% after five years.

TumorÂ necrosis greater than 95% is considered one of the most important prognostic factors.